STOP-CAD study informs optimal treatment strategy for cervical artery dissection

For patients with cervical artery dissection initially treated with anticoagulation, switching to antiplatelet therapy at 30 days may prevent bleeding events later, as stroke risk was lower by then, researchers reported.
The results of the STOP-CAD study were presented at the International Stroke Conference and simultaneously published in Stroke.
“Cervical artery dissection accounts for about 2% of ischemic strokes, but up to 25% of ischemic strokes in young adults,” Shadi Yaghi, MD, associate professor of neurology and vascular neurology division chief at The Warren Alpert Medical

For patients with cervical artery dissection initially treated with anticoagulation, switching to antiplatelet therapy at 30 days may prevent bleeding events later, as stroke risk was lower by then, researchers reported.
The results of the STOP-CAD study were presented at the International Stroke Conference and simultaneously published in Stroke.
“Cervical artery dissection accounts for about 2% of ischemic strokes, but up to 25% of ischemic strokes in young adults,” Shadi Yaghi, MD, associate professor of neurology and vascular neurology division chief at The Warren Alpert Medical